Open Access737 Economic Burden of Biologic Treatment in Patients With Inflammatory Bowel Disease in the U.S.
Author(s) -
Rebecca Bornheimer,
Steven Hass,
Arpita Nag,
Gerry Oster
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000592484.27433.a0
Subject(s) - medicine , inflammatory bowel disease , ulcerative colitis , cohort , biologic agents , disease , crohn's disease , biosimilar , vedolizumab